-The Times of India NEW DELHI: Rattled by the midday meal tragedy in Bihar in which 23 children have died, the Delhi government and the municipal corporations swung into action on Thursday. Officials of the Directorate of Education (DoE) led by Marcel Ekka, deputy director of the midday meal programme, visited many schools to take stock. Officials said, unlike other states, the situation in the national capital is better as none...

-The Economic Times CHENNAI: India's patent appeals board has denied Monsanto a patent for a genetically-engineered method of increasing climate resilience in plants. The decision is significant not only for Monsanto's loss of possible exclusivity in an increasingly important segment but also for the interpretation of India's home-grown clauses in patent law - these are unpopular with global companies - for the first time in the case of plants. The Intellectual Property...

-Kafila.org Over 115 women have signed a letter seeking an apology from Ms. Meenakshi Lekhi for her sexist slandering of deceased Ishrat Jahan in a television channel. The letter has also been sent to the Chairperson of the National Commission for Women for appropriate action. As the noose is tightening around the conspirators who cynically and coldly planned and executed the killing of teenaged Ishrat Jahan and three other people in 2004,...

-The Hindu     Ignou's dual talk leaves students in the lurch Nobody would have thought that in less than two years of setting up of the first Indian Sign Language Research & Training Centre (ISLRTC) for the hearing-impaired, plans would be afoot to shut it down. But that is what seems to be happening at the Indira Gandhi National Open University (Ignou) campus here. Vice-Chancellor M. Aslam categorically told The Hindu that there was...

-PTI India however maintained that the India Patent Act was in accordance with the TRIPS Agreement & the Paris Convention The US pharma industry has expressed concern over deteriorating intellectual property environment in India, alleging that patent rights in the country are unreasonably denied. "PhRMA remains concerned about the deteriorating intellectual property environment in India," Mark Grayson, PhRMA spokesman told PTI. The remarks by PhRMA or Pharmaceutical Research and Manufacturers of America, representing America's...